A new clinical trial titled “Intravenous Sedation and Analgesia Versus Local Anesthesia During Microwave Ablation of Benign Thyroid Nodules” has been announced by Suez University. The study, which is not yet recruiting, aims to compare the use of intravenous sedation with perithyroidal local anesthesia during the microwave ablation of benign thyroid nodules. This trial is poised to provide valuable insights for clinical, quality, and regulatory professionals seeking evidence-based solutions for patient care.
- What changed?
- How is the clinical trial structured?
- What are the potential outcomes?
- Frequently Asked Questions
- Conclusion
- Disclaimer
What changed?
The clinical trial, sponsored by Suez University, marks an important development in procedural approaches for benign thyroid nodule treatment. It evaluates two different anesthesia methods: moderate to deep sedation (as intravenous sedation and analgesia) and perithyroidal local anesthesia. The trial is registered on ClinicalTrials.gov and reflects the ongoing interest in improving patient experiences and outcomes during minimally invasive thyroid treatments.
The inclusion of microwave ablation in this trial highlights its growing adoption as a less invasive option for treating benign thyroid nodules, reducing the need for surgical resection in some cases. This research could influence procedural guidelines, anesthesia protocols, and patient selection criteria.
How is the clinical trial structured?
This randomized study is designed to measure the safety and effectiveness of two different anesthesia techniques applied during microwave ablation. In the first group, participants will receive moderate to deep sedation, utilizing intravenous analgesic agents. In the second group, perithyroidal local anesthesia will be administered. Both approaches will help define the clinical trade-offs related to patient comfort, procedural accuracy, and adverse effects.
Though recruitment has not yet begun, the trial will likely include defined eligibility criteria focusing on individuals with benign thyroid nodules requiring treatment. Enrollment and execution phases will adhere strictly to Good Clinical Practice (GCP) guidelines.
What are the potential outcomes?
The trial aims to determine which method ensures optimal procedural success with minimal complications. Parameters under observation may include levels of patient discomfort, recovery times, and occurrence of side effects like airway compromise or pain. Additional endpoints could involve assessing procedural efficiency and accuracy under varying anesthesia regimens.
The findings are expected to inform clinicians, quality specialists, and regulatory professionals about improving procedural safety and patient satisfaction. Rigorous data analysis will likely underpin subsequent recommendations or updates to clinical guidelines involving thyroid nodule ablation.
Frequently Asked Questions
- 1. What are benign thyroid nodules?
Benign thyroid nodules are non-cancerous growths in the thyroid gland, often asymptomatic, but some may require intervention due to size, symptoms, or risk of complications. - 2. What is microwave ablation?
Microwave ablation is a minimally invasive procedure that uses thermal energy to destroy diseased tissue, increasingly utilized for treating thyroid nodules without surgery. - 3. Why compare sedation and local anesthesia?
Comparing these anesthesia methods can help identify the most suitable option for balancing patient comfort, safety, and procedural outcomes in specific scenarios.
Conclusion
This trial offers an opportunity to advance the understanding of anesthesia’s role in microwave ablation for thyroid conditions. By comparing intravenous sedation and local anesthesia, the study could redefine procedural standards, ultimately enhancing patient experiences and therapeutic outcomes. Clinical, regulatory, and quality professionals should monitor the results closely to apply the findings to real-world practices.
Disclaimer
This article is intended for informational purposes only. It does not constitute legal or regulatory advice and should not replace professional consultation.
Announcement Link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07235605?term=medical+device